Suboxone Tooth Decay Lawsuit

The Suboxone litigation is expanding rapidly, with more than 11,000 lawsuits now centralized in MDL 3092 in the U.S. District Court for the Northern District of Ohio.

Plaintiffs allege that Suboxone sublingual film—used in opioid addiction treatment—has caused severe dental injuries, including tooth decay, gum disease, enamel erosion, and tooth loss.

Judge Philip Calabrese recently issued a new order allowing plaintiffs to use a “block filing” system, enabling up to 100 individuals to file in a single complaint.

This move aims to accelerate the litigation process and reduce barriers for affected individuals.

The lawsuits claim manufacturer Indivior failed to warn of the risks for years, despite increasing evidence of harm.

A dental injury warning was not added to the product’s label until June 2022, more than a decade after FDA approval.

A 2022 JAMA study found sublingual buprenorphine users experienced over twice the rate of dental issues compared to other forms.

The court previously ruled that failure-to-warn claims can proceed while narrowing some design defect arguments.

Bellwether trials are expected to begin in late 2025 or early 2026, and could significantly shape future settlement negotiations.

During the latest status conference in the Suboxone multidistrict litigation (MDL), the court approved key procedural agreements regarding document handling and the management of newly filed claims.

The parties agreed to redact prior deposition transcripts, finalize standardized medical release forms, and begin tracking claims filed after October 7, 2024.

Discussions also addressed the logistics of collecting documents from key individuals involved in the litigation.

Judge Calabrese resolved two contested issues related to the language in Rule 30(b)(6) deposition notices and directed the parties to continue meeting and conferring on another outstanding document dispute.

The court also set two important deadlines: one for submitting a plan to collect non-custodial documents and another for providing fact sheets outlining each side’s claims and defenses.

An in-person hearing has been scheduled for September 9 as the MDL continues to progress through discovery.

On July 14, 2025, U.S. District Judge Philip Calabrese reappointed nearly 30 attorneys to continue leading the Suboxone tooth decay multidistrict litigation (MDL No. 3092), currently centralized in the Northern District of Ohio.

The leadership team will remain responsible for managing pretrial activities, overseeing discovery, and preparing for upcoming bellwether trials in the rapidly expanding litigation.

The reappointment precedes a case management conference scheduled for July 15, 2025, where the court is expected to review the ongoing development and selection of bellwether cases.

To date, more than 11,000 lawsuits have been consolidated in the MDL, with plaintiffs alleging that Suboxone caused serious dental injuries—including tooth decay, tooth loss, and other oral health problems—and that the manufacturer failed to provide adequate warnings to users and healthcare professionals.

The litigation is advancing through a structured bellwether process.

Earlier this year, a pool of 500 cases was created for records collection, with 100 of those cases selected for more in-depth discovery.

That group will ultimately be narrowed to 15 cases, from which five will be chosen for early jury trials designed to test legal arguments and guide potential settlement efforts.

If the bellwether trials do not lead to a global resolution, remaining cases may be sent back to their original courts for individual trials.

The Suboxone multidistrict litigation (MDL) experienced a slight decline in case filings, with the total dropping from 896 in May to 892 in June.

While the decrease may be due to case consolidation or clerical adjustments, overall litigation activity remains steady.

Plaintiffs continue to allege that extended use of Suboxone film strips, which contain buprenorphine, caused serious dental injuries—including tooth decay, enamel erosion, jawbone damage, and tooth loss.

Attorneys are closely watching for rulings on Daubert motions that will determine whether expert testimony on Suboxone’s low pH and corrosive potential will be allowed at trial.

A case management conference is expected to address the timeline for selecting and scheduling early bellwether trials.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

On May 19, Judge Philip Calabrese approved a framework for selecting 50 Suboxone dental injury lawsuits to move forward into the bellwether discovery phase.

These cases will be drawn from a previously designated Records Collection Pool that includes 500 claims alleging that Suboxone film caused severe dental damage, including tooth decay and erosion.

To create a Core Discovery Pool, the court will first randomly select 100 cases from the larger pool.

From this group, plaintiffs and defendants will each select 15 cases, while the court will randomly add another 20 to complete the 50-case Core Discovery Pool.

These selected cases will then undergo focused discovery and may be considered for inclusion in a 15-case bellwether trial pool.

The court has not yet announced a schedule for choosing the final bellwether cases.

The next status conference in the multidistrict litigation is set for June 17.

The parties must submit a proposed agenda for that conference by June 13.

The Suboxone Lawsuit remains active, even as the total number of filings in the multidistrict litigation (MDL) has held steady at 896 over the past month.

Plaintiffs claim that long-term use of Suboxone, a medication used to treat opioid addiction, has resulted in severe dental problems such as tooth decay, enamel erosion, and tooth loss.

They allege that the manufacturers failed to adequately warn patients and healthcare providers about these risks.

Although no new cases were added this month, the litigation continues to move forward as individuals affected by Suboxone-related dental injuries pursue justice.

The absence of new filings does not reflect a lack of interest, but rather a period of preparation and consolidation within the ongoing legal process.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit continues to move forward in multidistrict litigation (MDL), as the court begins gathering medical records from plaintiffs.

A group of 500 plaintiffs has been randomly selected to form the “Record Collection Pool,” made up of 100 filed lawsuits and 400 cases currently under tolling agreements.

These individuals must now authorize the release of their medical records to help determine eligibility for early trial selection.

This collection process will conclude once 85% of the records have been obtained—a milestone expected to take about six months.

After that, both sides will begin selecting cases for the initial bellwether trials.

These early trials are designed to test the core claims of the litigation: that Suboxone film caused irreversible dental injuries, including tooth decay, erosion, and oral infections.

The outcome of the bellwether trials may help shape future Suboxone settlements and give insight into how juries may evaluate the drug’s dental risks.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

With the June 2025 deadline for filing Suboxone lawsuits approaching in states with a three-year statute of limitations, thousands of individuals suffering from tooth decay and other dental issues linked to Suboxone use are expected to take legal action.

Suboxone, prescribed for opioid addiction treatment, has been connected to severe dental damage, including tooth decay and loss, especially among users of the sublingual film version.

In June 2022, the manufacturer, Indivior, updated the drug’s warning label to acknowledge for the first time the risks of tooth decay and dental erosion.

This update led to a surge of lawsuits, resulting in over 10,000 claims being consolidated into a multidistrict litigation (MDL).

Many affected individuals were unaware of the connection between their dental problems and Suboxone until the label update, causing confusion about the start of the statute of limitations.

As a result, people in states with a three-year statute of limitations are rushing to file their claims before June 2025.

Missing this deadline could bar them from seeking compensation for their injuries.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The number of Suboxone Tooth Decay Lawsuits remained unchanged between March and April 2025, holding steady at 896 total cases.

This stability follows a period of rapid growth in filings earlier in the year.

The lawsuits allege that long-term use of Suboxone, a medication commonly prescribed to treat opioid addiction, caused significant dental problems—such as tooth decay, enamel erosion, and oral infections.

Plaintiffs claim that manufacturers failed to adequately warn users about these risks, despite growing reports of oral health complications.

As the litigation progresses, focus remains on discovery and bellwether trial planning, which could shape the direction of future Suboxone settlements.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit continues to grow, with a new bulk filing order now in effect.

U.S. District Judge Philip Calabrese, overseeing the MDL in the Northern District of Ohio, has approved a process allowing up to 100 plaintiffs with tooth decay claims to file together in a single complaint.

This aims to streamline the legal process and reduce filing costs. As the June 2025 statute of limitations deadline nears—three years after the FDA’s tooth decay warning—plaintiffs are encouraged to file promptly.

Over 10,000 lawsuits are currently pending.

The court has also ordered the formation of a Record Collection Pool, which will gather medical records from 500 randomly selected plaintiffs.

Bellwether trials are being prepared to help project jury outcomes and settlement values, with early results likely to shape the path forward for Suboxone settlements.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

In March 2025, the number of new filings in the Suboxone tooth decay litigation held steady at 896 cases, with no increase from the 896 cases reported in February 2025.

However, February saw a decrease of 142 cases compared to the previous month.

Our attorneys continue to monitor developments in the Suboxone Lawsuit and are actively assisting those affected in seeking compensation for the harm caused by Suboxone-related tooth decay.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

A federal judge overseeing the Suboxone tooth decay lawsuits has instructed pharmacies and medical providers to deliver the requested medical records within 30 days.

This decision is aimed at preventing delays in the expanding litigation.

Over 11,000 lawsuits allege that Suboxone film caused severe tooth decay. Plaintiffs’ attorneys are working to collect dental records and prescription histories to identify cases for early bellwether trials.

However, challenges in obtaining these records have hindered progress. Some providers have imposed inconsistent authorization protocols, complicating plaintiffs’ access to necessary documentation.

Judge Philip Calabrese, managing the multidistrict litigation (MDL) in the Northern District of Ohio, has mandated that providers accept electronic or ink-signed authorizations and refrain from imposing additional requirements like photo ID requests.

The next status conference is scheduled for March 11, with more Suboxone lawsuits anticipated ahead of the FDA’s 2022 label update on tooth decay risks.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone (buprenorphine/naloxone) Film Products Liability Litigation, MDL 3092, is currently working on establishing its bellwether protocol for trial cases.

This MDL consolidates lawsuits against the manufacturers of Suboxone Film, which claim that the product caused dental injuries.

The litigation is moving forward with organizing discovery procedures, including creating the Bellwether Pool of cases.

The Plaintiffs’ Liaison Counsel (PLC) has suggested increasing the core discovery pool to 50 plaintiffs, with up to 250 depositions, before selecting bellwether cases for trial.

The PLC is also in discussions with the defendants about the timeline for document and custodial file production.

A proposed case management order outlines how bellwether cases will be chosen.

A pool of 100 cases will be randomly selected, with plaintiffs required to submit proof of Suboxone use and dental injuries.

The bellwether process will proceed according to a set timeline, concluding with trial preparation in 2026.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

In February 2025, the number of Suboxone Tooth Decay Lawsuits in the MDL increased to 896, up by 142 cases from the 754 lawsuits reported in January 2025.

Plaintiffs allege that the drug, frequently used to treat opioid addiction, has led to severe tooth decay and other oral health problems.

This significant rise in filings indicates that more individuals are coming forward with similar claims and pursuing compensation for the damage caused.

As awareness of Suboxone’s potential dental side effects grows, the litigation continues to expand, with more affected individuals seeking justice for their oral health issues.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone multidistrict litigation (MDL) is expected to see a significant rise in case filings as a possible statute of limitations deadline looms in June 2025.

Individuals in states with a three-year limitations period may have their last chance to file claims against Suboxone’s manufacturers, alleging the opioid addiction treatment caused severe dental issues like tooth decay and erosion.

U.S. District Judge Philip Calabrese, overseeing the MDL in the Northern District of Ohio, has indicated that the court is preparing for a surge of new cases.

With no agreement on tolling measures between plaintiffs and defendants, each claimant will need to file separately before the deadline.

Established in 2024, the MDL consolidates over 10,000 lawsuits claiming the drugmaker failed to warn about Suboxone’s link to dental damage.

The warnings, added in June 2022 after an FDA mandate, have sparked allegations that earlier action could have prevented widespread harm.

A bundled complaint filed in 2024 included over 9,500 plaintiffs from states with shorter limitation periods.

The anticipated increase in filings will test the court’s capacity, with 8,600 cases still pending from the initial bundle.

Potential claimants are urged to act quickly to meet the June 2025 deadline and secure compensation for dental injuries and related damages.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

Teva Pharmaceuticals is actively working to dismiss cases before settlement discussions progress.

Recently, the company responded to a Show Cause Order from the Northern District of Georgia, pointing out deficiencies in a plaintiff’s documentation.

Teva issued a Deficiency Letter, highlighting procedural gaps.

This tactic reflects the company’s broader strategy of enforcing strict adherence to procedural requirements, which could decrease the number of active claims.

Meanwhile, efforts toward a global settlement continue.

Sixteen months ago, M. Gino Brogdon Sr., a retired judge, was appointed to oversee settlement talks in the multidistrict litigation (MDL).

Mediators play a vital role in resolving complex MDLs, and Brogdon’s involvement is expected to increase in 2025.

While optimism for a global settlement remains high, the timeline for resolution remains uncertain.

Both plaintiffs and defendants face pivotal moments, with procedural diligence and proactive negotiations playing a key role in shaping this high-profile litigation.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone MDL has made notable progress following the judge’s ruling on the Motion to Dismiss, which was roughly 80% favorable to the Plaintiffs.

Key claims, such as failure to warn and design defects, were allowed to proceed against the manufacturer.

However, the design defect claim for cases post-2010 was dismissed.

Plaintiffs will continue to pursue failure to warn claims, which now extend through 2022 but are limited to the defendant Indivior, responsible for the drug’s labeling.

Despite some setbacks related to Indivior, this ruling marks a significant victory for plaintiffs seeking compensation in the Suboxone Tooth Decay Lawsuits.

With the case entering a new phase focused on discovery, expert testimony, and bellwether trials, the next Case Management Conference on January 14, 2025, will shed light on the path forward for the rest of 2025, likely leading to further developments.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The number of Suboxone Lawsuits pending in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation increased from 716 in December 2024 to 754 in January 2025, marking an addition of 38 new cases.

Suboxone, a prescription drug widely used to treat opioid addiction, is the focus of litigation following reports that its sublingual formulation leads to severe tooth decay.

The growing number of case filings highlights the increasing legal action against the manufacturers of Suboxone as more individuals seek compensation for the drug’s harmful effects.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

This week marked a significant development in the Suboxone mass tort litigation, as oral arguments were heard for the Defendants’ Motion to Dismiss.

The motion, filed in June 2024, revolves around the preemption defense, a common strategy in mass tort cases involving FDA-approved drugs.

In such cases, manufacturers often argue that they cannot be held accountable under state laws because their products were federally approved, particularly by the FDA.

The Defendants contend that the FDA’s approval of Suboxone and the absence of confirmed adverse event reports restricted their ability to modify the label and warn about the possible risk of tooth decay.

The Plaintiffs, however, assert that FDA approval does not absolve manufacturers from their continuing obligation to monitor, report, and disclose risks, including those related to tooth decay, linked to Suboxone usage.

Judge Calabrese is anticipated to rule on the Motion to Dismiss before the next Case Management Conference, scheduled for January 14, 2025. 

If the Plaintiffs succeed, the case could proceed to discovery and potential trials, advancing claims for compensation due to Suboxone-related dental injuries.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

On December 16, a federal judge overseeing over 11,000 Suboxone tooth decay lawsuits heard oral arguments regarding a motion to dismiss filed by Indivior, the manufacturer of Suboxone film.

The motion is based on federal preemption, with Indivior asserting that federal law prevented it from updating the drug’s warning labels earlier, thereby shielding it from state-based failure-to-warn claims.

Plaintiffs allege that Indivior neglected to warn about the risk of severe dental damage, including tooth decay and enamel loss, despite widespread reports prior to a June 2022 label update.

They also contend that Indivior had a duty to inform users and medical professionals of these risks and argue that safer delivery methods for the drug’s active ingredients were available.

The lawsuits have been consolidated into a multidistrict litigation (MDL) under U.S. District Judge Philip Calabrese in the Northern District of Ohio.

Although the judge did not rule on the motion to dismiss, he has scheduled further case management conferences for April, May, and June 2025 to advance the litigation.

If the motion to dismiss is denied, the Court will likely select bellwether cases for early jury trials.

While these trials will not directly bind other claims, their outcomes could heavily influence potential Suboxone settlement negotiations, as jury verdicts will guide efforts to resolve the remaining lawsuits.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

Oral arguments for a motion to dismiss over 11,000 Suboxone tooth decay lawsuits are set for December 16.

Indivior, the manufacturer of Suboxone, contends that federal law preempted its ability to update the drug’s warning labels until June 2022.

The lawsuits claim that Suboxone, a sublingual film used for opioid addiction treatment, can degrade tooth enamel, causing dental decay, cavities, oral infections, and tooth loss.

Plaintiffs allege that Indivior was aware—or should have been aware—of these risks but failed to adequately warn users or provide guidance to prevent these issues.

The cases have been consolidated into multidistrict litigation (MDL) before U.S. District Judge Philip Calabrese in the Northern District of Ohio for coordinated pretrial proceedings.

Following a November status conference, Judge Calabrese will hear the oral arguments on December 16.

The court has requested a joint report by December 12 to identify any remaining issues for review.

Should the motion to dismiss be denied, the MDL will likely advance to the selection of bellwether cases, which could serve as representative trials for the broader litigation.

These early trials may influence settlement negotiations and determine potential compensation amounts for the unresolved lawsuits.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Judicial Panel on Multidistrict Litigation (JPML) reported 678 case filings in the Suboxone Tooth Decay lawsuit in November.

By December, the filings rose to 716, reflecting an increase of 38 cases.

This lawsuit centers on claims that Suboxone, an opioid addiction treatment, caused serious dental problems such as tooth decay and loss, with plaintiffs alleging that the manufacturer failed to adequately warn about these risks.

The rise in filings may be attributed to increased awareness among patients and healthcare providers about the link between Suboxone use and dental damage.

The litigation continues to grow as more plaintiffs come forward, seeking accountability for the alleged harm caused by the medication.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit centers on allegations that Suboxone, a drug used to treat opioid addiction, has led to severe dental problems such as extensive tooth decay, erosion, and loss.

Plaintiffs claim that Indivior, the drug’s manufacturer, failed to properly inform users about the potential risk of dental damage as a side effect of Suboxone.

In October, 674 cases had been filed related to Suboxone tooth decay claims, which increased slightly to 678 by November, adding 4 new cases.

This gradual rise suggests that more users are becoming aware of the dental risks tied to prolonged Suboxone use.

The drug’s impact on dental health may lead to painful, costly procedures, which significantly affects the well-being of individuals relying on Suboxone for opioid addiction management.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Lawsuit is ongoing. 

A multi-day status conference for the Suboxone Tooth Decay Lawsuit commenced on October 4, 2024, uniting plaintiffs, defendants, and the MDL judge overseeing Suboxone dental injury cases.

The goal is to finalize protocols for the upcoming discovery phase and early bellwether trials.

Over 11,000 claims allege that Suboxone, a sublingual film medication, led to severe dental issues like tooth decay and enamel damage, citing insufficient warnings from its manufacturer, Indivior.

A central focus of this conference is the development of a detailed census protocol requiring plaintiffs to provide comprehensive information about their injuries.

This census will help the court identify cases representative of the broader claims, aiding in the selection of cases for the initial bellwether trials.

These trials aim to gauge jury responses to evidence related to Suboxone’s alleged dental risks.

In response to increasing reports of dental issues, the FDA updated Suboxone’s labeling in June 2022 to include warnings about potential dental damage.

Plaintiffs argue that had Indivior issued earlier warnings and provided proper usage guidelines, many users could have avoided severe dental injuries.

Conference discussions include the steps needed for gathering additional case details, medical records, and adverse event reports.

These early trials will involve extensive discovery, including expert testimony on the link between Suboxone use and dental harm.

If you or a loved one used Suboxone and suffered severe tooth decay, you may qualify to file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Suboxone Lawsuit and connect with a Suboxone lawyer instantly.

The Suboxone Tooth Decay Lawsuit centers on claims that the drug, used to treat opioid addiction and opioid use disorder (OUD), leads to serious dental issues, including tooth decay, loss, and other oral health complications.

Plaintiffs argue that the manufacturers of Suboxone did not provide sufficient warnings about the drug’s side effects, particularly its potential to cause significant dental damage.

In both September and October, the Judicial Panel on Multidistrict Litigation (JPML) reported 674 active Suboxone tooth decay lawsuits.

Users of Suboxone have reported severe dental problems, such as rapid tooth decay and tooth loss, requiring expensive treatments like root canals, dentures, or implants.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Lawsuit is ongoing.

In a recent update on the Suboxone MDL, an Ohio federal judge dismissed Indivior PLC and two Reckitt Benckiser entities from the lawsuits alleging that Suboxone, a treatment for opioid addiction, caused dental decay.

U.S. District Judge J. Philip Calabrese issued the dismissal following an agreement reached between the parties involved.

The claim filed by plaintiff Ryan Bennett was dismissed with prejudice, meaning it cannot be refiled, while other claims in the MDL were dismissed without prejudice, allowing those cases to potentially be brought again in the future.

The litigation focuses on allegations that the companies failed to warn consumers about the acidic properties of Suboxone’s dissolvable film, which could damage teeth.

Although Indivior and Reckitt Benckiser have been dismissed from the MDL, the litigation continues against other defendants, including Aquestive Therapeutics Inc.

The MDL, which was consolidated in February 2024, now includes claims from multiple states.

This follows Indivior’s earlier settlement of antitrust claims in a separate Suboxone case.

If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.

The Suboxone Lawsuit is ongoing. 

The Suboxone Lawsuit, which saw a surge of activity earlier this year due to concerns about the statute of limitations, has been relatively quiet recently.

However, this is expected to change as we near the end of 2024.

Litigation is expected to gain momentum as defendants are scheduled to produce key documents and custodial files that plaintiffs will likely receive before year-end.

A pivotal moment in the case will occur on October 4, 2024, when the oral argument for the Defendants’ Motion to Dismiss (MTD) based on preemption will take place.

If plaintiffs successfully challenge the MTD, the lawsuit will proceed rapidly, with the bellwether trial process likely being agreed upon, and defendants will start to receive case-specific disclosures.

This could mark a significant turning point in the Suboxone Tooth Decay Lawsuit, with substantial developments expected in the months ahead.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact TruLaw for a free consultation. Use the chatbot on this page to see if you qualify to file a Suboxone Lawsuit instantly.

The Suboxone Tooth Decay Lawsuit, which addresses claims that Suboxone use has resulted in severe dental problems, continues to see a slight rise in filings.

In August 2024, there were 673 active cases, which increased marginally to 674 by September 2024.

Plaintiffs in this lawsuit claim that Suboxone users have suffered from significant tooth decay despite maintaining proper dental hygiene, and they argue that the manufacturer did not provide sufficient warnings about these risks.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit involves claims against the drug’s manufacturer regarding an increased risk of severe tooth decay and other dental injuries.

In July, there were 677 filings in the Suboxone lawsuit, which slightly decreased to 673 by August.

Suboxone, a medication used to manage opioid addiction, has been associated with severe tooth decay, including cavities, tooth loss, and other dental problems.

Many affected individuals have filed lawsuits against Indivior, alleging that the company failed to adequately warn about these dental risks, leading to significant health complications and financial burdens for dental treatments.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

Suboxone Lawsuits are advancing with submission dates in August 2024 and a potential settlement timeline extending into mid-2025.

The litigation is continuing to grow, and lawyers are still accepting new Suboxone claims.

In June 2024, there were 258 Suboxone Lawsuit filings reported by the JPML.

By July 2024, the number of Suboxone Lawsuits had increased to 677.

Key submission dates for claim information and party proposals:

• August 27th, 2024
• August 27th, 2024

These documents are vital for progressing the litigation and may significantly impact the direction of the case.

Settlement Timeline:

• Settlement discussions are expected to extend into mid-2025.
• The earliest potential settlement by June 2025, pending resolution of ongoing issues within the litigation.

Tolling Agreement:

• Progress report due on August 1st, 2024.
• The tolling agreement pauses the statute of limitations, allowing time for comprehensive case preparation.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit is ongoing.

The number of Suboxone lawsuits has increased as more patients report severe tooth decay and other dental problems associated with the medication, seeking legal support from Suboxone Lawyers.

Suboxone Tooth Decay Lawsuits involve claims of dental injuries resulting from the use of the drug, a medication used for opioid addiction treatment.

The core arguments in the Suboxone Tooth Decay Lawsuits revolve around:

• Failure to Warn: Plaintiffs argue that the manufacturers did not provide adequate warnings about the risk of severe tooth decay associated with Suboxone.
• Negligent Design: Allegations include that the design of Suboxone contributes to an increased risk of dental problems, including tooth decay.
• Lack of Adequate Instructions: Many lawsuits claim that the manufacturers failed to provide proper instructions on how to minimize dental risks while using Suboxone.

In response to the increasing litigation, healthcare professionals recommend the following precautions for those using Suboxone:

• Maintain Oral Hygiene: Follow a strict oral hygiene routine, including brushing and flossing regularly.
• Regular Dental Check-Ups: Schedule frequent dental check-ups to monitor and address any early signs of tooth decay.
• Discuss with Your Doctor: Talk to your healthcare provider about the potential dental risks and ways to mitigate them while using Suboxone.

If you or a loved one has suffered from dental issues due to Suboxone, contact TruLaw for a free consultation.

The Suboxone lawsuit is ongoing. 

The Suboxone lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused severe dental issues, including tooth decay, tooth loss, and other dental problems.

This lawsuit seeks to hold the manufacturer accountable for these adverse effects.

In June, there were 258 Suboxone lawsuit filings.

By July, this number increased to 677.

Suboxone can cause significant dental problems, leading to tooth decay and tooth loss.

These issues have prompted more individuals to join the Suboxone lawsuit.

If you or a loved one has been negatively affected by suboxone, call today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

Recently, more than 9,600 individuals have joined a mass lawsuit against the producers of Suboxone, filing their claims shortly before a crucial deadline that might have affected eligibility in numerous states.

Suboxone, a medication used to treat opioid addiction, has been associated with significant dental problems, including tooth decay and irreversible damage.

This drug combines buprenorphine and naloxone and is widely prescribed to alleviate symptoms of opioid withdrawal.

Initially approved in tablet form in 2002, its sublingual film variant was launched around 2012.

The plaintiffs claim this film version was created to stave off generic competition and did not adequately warn of dental health risks.

It was not until June 17, 2022, after multiple reports of tooth loss, that the FDA mandated a warning for tooth decay.

As we near the second anniversary of this FDA warning update, there are already about 500 Suboxone lawsuits pending in federal courts.

These cases are under the supervision of U.S. District Judge Philip Calabrese in the Northern District of Ohio, grouped together in a multidistrict litigation (MDL) initiated in February 2024 to facilitate coordinated discovery and pretrial activities.

Judge Calabrese is expected to implement a bellwether process, selecting specific cases for early trial that will help guide subsequent settlement discussions.

If you or someone you know has experienced serious tooth decay after using Suboxone, you might be eligible to join the Suboxone Lawsuit. 

Contact us for a complimentary consultation, or use the chatbot on this page for an instant eligibility assessment for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is ongoing, and our lawyers are accepting new clients.

The U.S. District Judge overseeing the consolidated Suboxone dental decay lawsuits has initiated a Leadership Development Committee (LDC) to streamline case management and enhance legal representation across the MDL.

This committee is part of the mass tort litigation process, focusing on the widespread claims that Suboxone film causes severe dental decay, a side effect previously undisclosed by the drug’s manufacturer.

Suboxone is a medication used to treat opioid addiction, but the sublingual film version of the drug introduced in 2012 has been linked to significant dental health issues, including enamel erosion, tooth decay, cavities, oral infections, and loss of teeth.

It wasn’t until June 17, 2022, that the FDA mandated warnings about the risk of tooth decay on the medication’s labeling, spurred by numerous patient complaints.

Plaintiffs allege that an earlier warning could have prevented irreversible dental damage.

Approximately 350 product liability lawsuits are pending in the MDL, with numbers expected to surge as the two-year anniversary of the label update approaches, signaling a potential deadline for new claims.

These cases have been centralized in the Northern District of Ohio under Judge Philip Calabrese for coordinated pretrial proceedings.

If you or a loved one used Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Suboxone Tooth Decay Lawsuit instantly.

The Suboxone Tooth Decay Lawsuit is actively proceeding, and our attorneys are currently welcoming new clients.

According to the most recent updates from the Judicial Panel on Multidistrict Litigation (JPML), 258 lawsuits have been grouped into the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.

These lawsuits claim that Suboxone, particularly when used as a sublingual film or tablet, significantly increases the risk of severe tooth decay due to the prolonged exposure of teeth to substances that promote decay.

The litigation consolidates these claims into a single federal court, focusing on the severe dental issues allegedly caused by Suboxone.

If you or someone you know has experienced serious tooth decay after using Suboxone, you might be eligible to join the Suboxone Lawsuit. 

Contact us for a complimentary consultation, or use the chatbot on this page for an instant eligibility assessment for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit continues to progress. 

Plaintiffs are advocating for a tolling agreement in this multi-district litigation (MDL) to pause the statute of limitations, allowing more claims for dental injuries from Suboxone.

Since November 2023, the necessity of this agreement has been a focal point for effective litigation management.

As of May 2024, there are nearly 500 pending cases in the lawsuit. Without a tolling agreement, there’s a risk of an overflow of potentially unapproved claims, which could complicate the MDL’s objective to streamline these cases.

Defendants have consistently rejected the tolling agreement, a move plaintiffs see as a tactic to increase litigation challenges, possibly deterring weaker claims and adding complexity to the process.

Controversy also surrounds the Suboxone warning label, updated on June 17, 2022, to include risks of dental decay and tooth erosion.

Plaintiffs propose that the court should require defendants to respond to each complaint.

Impending court decisions will likely influence the lawsuit’s trajectory, affecting strategies of both parties involved.May 1, 2024:

The Suboxone Lawsuit is currently active.

There are now 205 lawsuits consolidated in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, as reported in the latest JPML filings.

This represents a significant increase, with 161 cases added to the litigation in the past month alone, up from just 44 cases on April 1st.

The lawsuits allege that Suboxone’s formulation, particularly when used as a sublingual film or tablet, leads to prolonged exposure of the teeth to substances that can cause decay.

The Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation centralizes claims that Suboxone is linked to severe tooth decay in a single federal court.

If you or someone you know has experienced severe tooth decay after using Suboxone, you might be eligible to participate in a Suboxone Lawsuit.

Contact us for a free consultation.

Additionally, you can instantly check if you qualify for the Suboxone Tooth Decay Lawsuit by using the chatbot on this page.

As of April 1st, the Judicial Panel on Multidistrict Litigation (JPML) reports a decrease in the number of pending Suboxone Lawsuits to 44, down from 51 on March 1st.

These lawsuits have been filed by individuals who used Suboxone for opioid addiction treatment and subsequently suffered severe tooth decay and other dental injuries.

In 2022, the FDA mandated that manufacturers include warning labels on Suboxone packaging to alert consumers about potential dental issues.

However, claims suggest that many users were not adequately warned about these risks prior to this mandate.

If you or a loved one has been affected by Suboxone contact us today for a free consultation.

Alternatively, use the chatbot on this page for an instant Suboxone Tooth Decay lawsuit evaluation. 

The Suboxone Tooth Decay Lawsuit continues, and our attorneys are open to representing new clients.

The United States District Court for the Northern District of Ohio has facilitated the submission of dental injury lawsuits related to Suboxone film by enabling plaintiffs to directly file their cases in this court within the broader framework of Multidistrict Litigation (MDL) No. 3092.

Suboxone, a medication prescribed for opioid addiction treatment, combines buprenorphine to lessen withdrawal symptoms with naloxone to prevent misuse.

Risks associated with Suboxone, especially the versions that dissolve orally, include significant tooth decay, cavities, and tooth loss.

This direct filing system expedites the legal process by eliminating the requirement for lawsuits to be transferred from various jurisdictions to this centralized court.

While plaintiffs have the choice to file their lawsuits directly in this MDL, it is not mandatory.

Lawyers nationwide are able to represent their clients in this MDL without the need for special authorization or additional fees, making the process more streamlined for plaintiffs.

Plaintiffs in their submissions are encouraged to propose a trial venue that has personal relevance to their case, such as their residence, the location where Suboxone was prescribed, or where it was used.

While this does not ensure the trial will occur in the proposed location, it aids in the organization of cases within the MDL structure.

This initiative by the Northern District of Ohio aims to make the legal process more accessible and efficient for those pursuing claims for dental damages allegedly caused by the use of Suboxone film and tablets that dissolve in the mouth.

If you or someone you know has experienced dental problems, tooth decay, oral infections, or other dental injuries after using Suboxone, you might be eligible to participate in the Suboxone Tooth Decay Lawsuit.

For a complimentary consultation, contact us today, or use the chatbot on this webpage for an instant assessment of your eligibility for the Suboxone Lawsuit.

The Suboxone Litigation continues, and our legal team is actively taking on new cases.

As of March 19th, the number of cases consolidated into the Multidistrict Litigation (MDL) focusing on Suboxone-related tooth decay has reached 51.

MDLs are essential for handling multiple lawsuits that have similar facts, especially in areas like pharmaceuticals, product defects, and complex legal matters, efficiently.

This consolidation process for the Suboxone cases facilitates the streamlining of the discovery process, the sharing of evidence, and the speeding up of individual lawsuits.

The formation of an MDL for Suboxone Lawsuits is a significant step in their handling and potential settlement.

It enables the pooling of resources, which supports a stronger legal approach bolstered by thorough expert analyses and investigative work.

Those who have suffered from dental problems due to Suboxone use now have a chance to seek legal recourse and may join a collective effort to obtain compensation.

The creation of this MDL highlights a dedication to securing justice for individuals who have endured dental harm as a side effect of their treatment for addiction.

If you or a loved one has faced serious dental issues as a consequence of using Suboxone, you may have the right to pursue legal action. 

By using the chatbot on this page, you can quickly assess whether you qualify to file a Suboxone Lawsuit and get connected with a specialized Suboxone lawyer.

The Suboxone Litigation remains active, with our legal team continuing to accept new cases.

The Northern District of Ohio now serves as the consolidation point for the Suboxone Tooth Decay Lawsuit, as determined by the Judicial Panel on Multidistrict Litigation (JPML).

According to the latest JPML updates, eleven lawsuits have been merged into this new Multi-District Litigation (MDL).

MDLs in the United States are established to efficiently manage multiple civil cases that share common legal issues, facts, or defendants.

This legal mechanism is particularly useful when a large number of lawsuits are filed across various jurisdictions, sharing a commonality such as tooth decay claims from Suboxone usage.

These cases are then combined in a single federal district court to undergo pretrial processes together.

The goal of an MDL is to streamline the legal process by centralizing discovery efforts, minimizing repetitive tasks, and ensuring uniform decisions on pivotal legal matters.

For individuals affected by dental problems attributed to Suboxone, the establishment of an MDL offers a pathway to collectively seek compensation through mass tort litigation.

The creation of an MDL for Suboxone Tooth Decay marks an important move towards achieving justice for individuals who have experienced tooth decay or other dental injuries as a result of using this opioid treatment medication.

If you or someone you care about has endured severe tooth decay following Suboxone use, you might have grounds to pursue legal action and file a lawsuit.

The chatbot on this page can assist in determining your eligibility to file a Suboxone Lawsuit and connect you with a qualified Suboxone attorney.

The Suboxone Tooth Decay Lawsuit is ongoing.

Indivior has reached a $385 million settlement to resolve claims from drug wholesalers in the U.S., accusing the company of illegally hindering generic versions of its opioid addiction medication, Suboxone.

This agreement concludes protracted legal disputes over Suboxone, adding to previous settlements of $102.5 million in June with U.S. states and $30 million in August to address a class action from health plans.

The settlement avoids a trial that was set for October 30, involving around 70 Suboxone purchasers.

Suboxone was approved in the U.S. in 2002, with Indivior enjoying exclusive rights until 2009.

The legal challenge centered on allegations that Indivior transitioned to a film version of Suboxone to unlawfully maintain its market dominance as generics were poised to introduce more affordable tablet options.

In addition to this settlement, Indivior agreed in 2020 to a $600 million payment to settle charges by the U.S. government related to the fraudulent marketing of Suboxone.

Opioid-related overdoses have been implicated in more than 900,000 deaths in the U.S. since 1999, as reported by the CDC.

Mark Crossley, CEO of Indivior, stated that this settlement provides more predictability for the company’s stakeholders and emphasized that the agreement does not include an admission of liability.

The settlement awaits approval from the United States District Court for the Eastern District of Pennsylvania, with the payment anticipated to occur the following month.

If you or someone close to you has experienced severe tooth decay after using Suboxone, you might be entitled to pursue a lawsuit.

The chatbot on this page can assist in determining your eligibility for a Suboxone Lawsuit and connect you with a qualified attorney specializing in Suboxone cases.